Alveolar echinococcosis – rare cystic disease of the liver – editorial
Authors:
František Stejskal 1,2,3
Authors‘ workplace:
I. infekční klinika 2. LF UK a Nemocnice Na Bulovce Praha, přednosta doc. MUDr. Dušan Pícha, CSc.
1; Infekční oddělení Krajské nemocnice Liberec a. s., primář MUDr. Adam Vitouš
2; Ústav imunologie a mikrobiologie 1. LF UK a VFN Praha, přednostka prof. RNDr. Libuše Kolářová, CSc.
3
Published in:
Vnitř Lék 2015; 61(6): 509-510
Category:
Editorials
Labels
Diabetology Endocrinology Internal medicineArticle was published in
Internal Medicine
2015 Issue 6
Most read in this issue
- Diagnosing and therapy of gout
- “Stressful holiday” – takotsubo cardiomyopathy
- Guidelines of Czech Association for Thrombosis and Haemostasis of the Czech Medical Association of J. E. Purkyně for safety treatment with new oral anticoagulants (NOAC) – dabigatran etexilate, apixaban and rivaroxaban
- Alveolar echinococcosis – rare cystic disease of the liver – editorial